Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of oral sustained-release solid preparation with vinpocetine as active ingredient

A vinpocetine, slow-release solid technology, applied in the field of medicine, can solve the problems of low patient compliance and frequent drug administration

Inactive Publication Date: 2011-12-21
FUKANGREN BIO PHARMA
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the current clinical oral vinpocetine common preparations require frequent administration and low patient compliance, so the development of sustained-release vinpocetine preparations is in line with clinical needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of oral sustained-release solid preparation with vinpocetine as active ingredient
  • A kind of oral sustained-release solid preparation with vinpocetine as active ingredient
  • A kind of oral sustained-release solid preparation with vinpocetine as active ingredient

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1 Vinpocetine sustained-release tablet

[0035] Make 1000 Vinpocetine slow-release tablets with the raw materials of following weight ratio

[0036] Extended release partial prescription:

[0037]

[0038] Sustained release part preparation process:

[0039] 1. Pass succinic acid through a 100-mesh sieve, crush vinpocetine, pass through a 100-mesh sieve, and set aside.

[0040] 2. Take carnauba wax, stearic acid, and succinic acid, heat in a water bath at 90°C, stir, and melt, add succinic acid, stir evenly, add vinpocetine, and stir evenly. Stirring was continued, the water bath was removed, and the mass was allowed to cool. A waxy lump was obtained.

[0041] 3. Pulverize the waxy block obtained above, pass through a 60-mesh sieve, add microcrystalline cellulose, pregelatinized starch, and colloidal silicon dioxide, and mix well.

[0042] 4. Add magnesium stearate / SDS (94 / 6) as a lubricant and mix well.

[0043] 5. Prepare 6% Opadry common coating a...

Embodiment 2

[0045] Embodiment 2 Vinpocetine slow-release dry suspension

[0046] Extended release partial prescription:

[0047]

[0048]

[0049] Sustained release part preparation process:

[0050] 1. Pass succinic acid through a 100-mesh sieve, crush vinpocetine, pass through a 100-mesh sieve, and set aside.

[0051] 2. Take carnauba wax, stearic acid, and succinic acid, heat in a water bath at 90°C, stir, and melt, add succinic acid, stir evenly, add vinpocetine, and stir evenly. Stirring was continued, the water bath was removed, and the mass was allowed to cool. A waxy lump was obtained.

[0052] 3. Crush the waxy block obtained above, pass through a 60-mesh sieve, add microcrystalline cellulose, pregelatinized starch, and colloidal silicon dioxide, mix well, add water-based soft materials, extrude and spheronize to make pellets, During the spheronization process, talcum powder is continuously added, and the particle size is 0.5-1.0mm. Sustained-release pellets 1 were obtai...

Embodiment 3

[0069] Embodiment 3: common tablet

[0070] Make 1000 Vinpocetine tablets with the raw materials of following weight ratio

[0071] prescription:

[0072]

[0073] Preparation Process:

[0074] 1. Crush Vinpocetine, pass through a 100-mesh sieve, and set aside.

[0075] 2. Take microcrystalline cellulose and lactose, grind them through a 60-mesh sieve, and set aside.

[0076] 3. Take microcrystalline cellulose, lactose, vinpocetine, and HPMC K4M and mix them uniformly using the method of equal volume increments. Use purified water as a binder to make soft materials, granulate with 24 sieves, dry at 60°C, and control the moisture at 3-5%, granulated with 40 mesh sieve.

[0077] 4. Add magnesium stearate as a lubricant and mix well. Tablet.

[0078] 5. Carry out film coating to above-mentioned plain tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to an oral sustained-release solid preparation with vinpocetine as an active ingredient. It is an oral sustained-release solid preparation made from vinpocetine and its salts and pharmaceutically acceptable auxiliary materials through preparation technology. The oral sustained-release solid preparations involved in the present invention include but not limited to tablets, capsules, granules and sustained-release pellets. The quality is stable, controllable, safe and effective.

Description

technical field [0001] The invention relates to an oral sustained-release solid preparation with vinpocetine as the main component. It is a solid preparation made from vinpocetine and pharmaceutically acceptable auxiliary materials through preparation technology. The oral sustained-release solid preparation of the invention is stable in quality, controllable, safe and effective. It belongs to the field of medical technology. Background technique [0002] Vinpocetine (vinpoeetine.VIN) is a derivative of the indole alkaloid vincamine extracted from the vinca flower of the family Apocynaceae. Chemical name: ethyl(13as,13bs)-13a-ethyl-2,3,5,6-13a,13b hexahydro-1H-indole[3,2,1-de]pyridine[3,2,1 -ij][1,5]-naphthyridine-12-carboxylic acid, chemical structural formula: [0003] [0004] Vinpocetine is a brain circulation metabolism improving agent, which can selectively improve brain blood circulation, promote brain energy metabolism, regulate the function of neurotransmitter...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K9/22A61K9/52A61K31/4375A61K47/44A61K47/38A61K47/36A61K47/34A61K47/32A61P9/00A61P25/00
Inventor 不公告发明人
Owner FUKANGREN BIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com